Corin secures top position in Taiwan's hip market:
This article was originally published in Clinica
Executive Summary
Corin Medical has won a contract to supply hip implants to the Chang Guan Memorial Hospital in Taipei, Taiwan. The contract, valued at £1-2 million ($1.5-3 million) over a minimum of two years, is the largest ever awarded to Corin. Reflecting the UK company's "aggressive expansion" in the Far East, the deal will make Corin the leading supplier of orthopaedic replacement devices in Taiwan.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.